← Evidence map

ArticleFrontiers in pharmacology2025

Onvansertib exhibits anti-proliferative and anti-invasive effects in endometrial cancer.

Nikita Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40166466